<p>Liquidia（纳斯达克：LQDA - 获取免费报告）在周四发布的研究报告中，被华尔街 Zen 的股票研究分析师从 “卖出” 评级上调至 “持有” 评级。</p>
<ul>
<li>MarketBeat 周回顾：12/25 - 12/29</li>
</ul>
<p>其他几位分析师最近也对 LQDA 发表了看法。加拿大丰业银行在 5 月 5 日的研究报告中重申了对 Liquidia 股票的 “跑赢大盘” 评级。Oppenheimer 将 Liquidia 的评级从 “市场表现” 下调至 “表现不佳”，并设定了 13.00 美元的目标价。Needham &amp; Company LLC 在周三的研究报告中重新发布了 “买入” 评级，并设定了 25.00 美元的目标价。Raymond James 在 5 月 9 日的研究报告中将 Liquidia 的目标价从 27.00 美元上调至 29.00 美元，并给予该公司 “强力买入” 评级。最后，HC Wainwright 在 5 月 12 日的报告中重申了 “买入” 评级，并对 Liquidia 股票设定了 29.00 美元的目标价。一位股票研究分析师给予该股票 “卖出” 评级，一位给予 “持有” 评级，六位给予 “买入” 评级，两位给予 “强力买入” 评级。根据 MarketBeat.com 的数据，Liquidia 的共识评级为 “适度买入”，平均目标价为 25.56 美元。</p>
<p><strong>阅读我们对 Liquidia 的最新分析</strong></p>
<h2>Liquidia 股票下跌 3.0%</h2>
<ul>
<li>Liquidia：法院胜利是行业巨头的觉醒？</li>
</ul>
<p>周四交易时段，LQDA 的股价下跌 0.50 美元，达到 16.16 美元。该公司交易了 561,016 股，低于其平均交易量 1,039,819 股。该公司的市值为 13.8 亿美元，市盈率为-9.94，贝塔值为 0.24。Liquidia 的 12 个月低点为 8.26 美元，12 个月高点为 19.41 美元。该公司的 50 日移动平均价格为 14.72 美元，200 日移动平均价格为 13.50 美元。</p>
<p>Liquidia（纳斯达克：LQDA - 获取免费报告）于 5 月 8 日发布了季度财报。该公司报告每股收益为（0.45 美元），低于市场共识预期的（0.42 美元）3 美分。该公司季度收入为 312 万美元，而分析师预期为 323 万美元。Liquidia 的净利润率为-765.38%，股本回报率为-163.21%。分析师平均预计 Liquidia 在本年度的每股收益为-1.51 美元。</p>
<h2>Liquidia 的内部交易</h2>
<p>在相关消息中，首席法律顾问 Russell Schundler 在 4 月 14 日的交易中出售了 5,964 股股票，平均售价为 13.57 美元，总交易额为 80,931.48 美元。交易完成后，首席法律顾问现在直接持有 570,301 股公司股票，价值约为 7,738,984.57 美元。这代表其持股比例减少了 1.03%。该出售在向 SEC 提交的文件中披露，文件可通过此超链接访问。此外，内部人士 Jason Adair 在 4 月 14 日的交易中出售了 1,856 股公司的股票，平均售价为 13.57 美元，总交易额为 25,185.92 美元。交易完成后，内部人士现在持有 184,304 股公司股票，价值为 2,501,005.28 美元。这代表其持股比例减少了 1.00%。该出售的披露信息可以在这里找到。在过去的九十天里，内部人士共出售了 33,138 股公司股票，价值为 450,233 美元。当前 26.50% 的股票由内部人士持有。</p>
<h2>对 Liquidia 的对冲基金看法</h2>
<p>一些大型投资者最近修改了他们对 LQDA 的持股。Bluefin Capital Management LLC 在第一季度购买了 Liquidia 的新头寸，价值约为 250,000 美元。瑞银资产管理美国分部在第一季度将其在 Liquidia 的持股增加了 15.2%。瑞银资产管理美国分部现在持有 121,756 股公司股票，价值为 1,796,000 美元，此前在上个季度又增持了 16,022 股。高盛集团在第一季度将其在 Liquidia 的持股增加了 10.7%。高盛集团现在持有 861,231 股公司股票，价值为 12,703,000 美元，此前在此期间又增持了 82,955 股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Liquidia 的持股增加了 4.7%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.现在持有 37,681 股公司股票，价值为 556,000 美元，此前在上个季度又增持了 1,700 股。最后，Boothbay Fund Management LLC 在第一季度将其在 Liquidia 的持股增加了 18.7%。Boothbay Fund Management LLC 现在持有 662,873 股公司股票，价值为 9,777,000 美元，此前在上个季度又增持了 104,215 股。当前 64.54% 的股票由机构投资者持有。</p>
<h2>Liquidia 公司简介</h2>
<p>（获取免费报告）</p>
<p>Liquidia Corporation 是一家生物制药公司，开发、生产和商业化各种满足美国患者需求的产品。其主要产品候选包括 YUTREPIA，一种用于治疗肺动脉高压（PAH）和与间质性肺病相关的肺高压（PH-ILD）的吸入干粉制剂。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票，胜过 Liquidia</li>
<li>外汇是什么，如何运作？</li>
<li>这些是 NVIDIA 13F 投资组合中仅有的 6 只股票</li>
<li>什么是股息收割策略，投资者如何从中获利？</li>
<li>Snowflake 突破！它能在 2025 年及以后继续上涨吗？</li>
<li>百分比涨幅告诉投资者什么，以及为什么它们不能告诉全部故事</li>
<li>3 只长期投资者在任何市场中都能喜爱的买入持有股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TFFEQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TFFEQQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Liquidia 吗？</h2>
<p>在考虑 Liquidia 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Liquidia 并不在名单上。</p>
<p>虽然 Liquidia 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

LQDA

<p>华尔街禅将 Liquidia（NASDAQ:LQDA）的评级从 “卖出” 上调至 “持有”。其他分析师的看法不一，苏格兰银行维持 “跑赢大盘” 的评级，而奥本海默则将其下调至 “跑输大盘”，目标价为 13 美元。Liquidia 的股价下跌 3%，至 16.16 美元，市值为 13.8 亿美元。该公司报告季度每股亏损 0.45 美元，未能达到预期。内部交易显示出一些卖出活动，对冲基金最近也调整了在该公司的持股</p>

<p>Liquidia (NASDAQ:LQDA - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a research note issued on Thursday.</p>
<div class="lb-trans"><p>Liquidia（纳斯达克：LQDA - 获取免费报告）在周四发布的研究报告中，被华尔街 Zen 的股票研究分析师从 “卖出” 评级上调至 “持有” 评级。</p>
</div><ul>
<li>MarketBeat Week in Review: 12/25 - 12/29</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾：12/25 - 12/29</li>
</ul>
</div><p>Several other analysts also recently weighed in on LQDA. Scotiabank restated an &#34;outperform&#34; rating on shares of Liquidia in a research report on Monday, May 5th. Oppenheimer downgraded Liquidia from a &#34;market perform&#34; rating to an &#34;underperform&#34; rating and set a $13.00 target price on the stock. in a report on Monday. Needham &amp; Company LLC reissued a &#34;buy&#34; rating and set a $25.00 price target on shares of Liquidia in a research report on Wednesday. Raymond James lifted their price objective on shares of Liquidia from $27.00 to $29.00 and gave the company a &#34;strong-buy&#34; rating in a research note on Friday, May 9th. Finally, HC Wainwright restated a &#34;buy&#34; rating and issued a $29.00 target price on shares of Liquidia in a report on Monday, May 12th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, six have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, Liquidia has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $25.56.</p>
<div class="lb-trans"><p>其他几位分析师最近也对 LQDA 发表了看法。加拿大丰业银行在 5 月 5 日的研究报告中重申了对 Liquidia 股票的 “跑赢大盘” 评级。Oppenheimer 将 Liquidia 的评级从 “市场表现” 下调至 “表现不佳”，并设定了 13.00 美元的目标价。Needham &amp; Company LLC 在周三的研究报告中重新发布了 “买入” 评级，并设定了 25.00 美元的目标价。Raymond James 在 5 月 9 日的研究报告中将 Liquidia 的目标价从 27.00 美元上调至 29.00 美元，并给予该公司 “强力买入” 评级。最后，HC Wainwright 在 5 月 12 日的报告中重申了 “买入” 评级，并对 Liquidia 股票设定了 29.00 美元的目标价。一位股票研究分析师给予该股票 “卖出” 评级，一位给予 “持有” 评级，六位给予 “买入” 评级，两位给予 “强力买入” 评级。根据 MarketBeat.com 的数据，Liquidia 的共识评级为 “适度买入”，平均目标价为 25.56 美元。</p>
</div><p><strong>Read Our Latest Analysis on Liquidia</strong></p>
<div class="lb-trans"><p><strong>阅读我们对 Liquidia 的最新分析</strong></p>
</div><h2>Liquidia Stock Down 3.0%</h2>
<div class="lb-trans"><h2>Liquidia 股票下跌 3.0%</h2>
</div><ul>
<li>Liquidia: Court victory the awakening of an industry giant?</li>
</ul>
<div class="lb-trans"><ul>
<li>Liquidia：法院胜利是行业巨头的觉醒？</li>
</ul>
</div><p>Shares of LQDA traded down $0.50 during trading hours on Thursday, reaching $16.16. 561,016 shares of the company traded hands, compared to its average volume of 1,039,819. The company has a market capitalization of $1.38 billion, a price-to-earnings ratio of -9.94 and a beta of 0.24. Liquidia has a 12 month low of $8.26 and a 12 month high of $19.41. The company's fifty day moving average price is $14.72 and its two-hundred day moving average price is $13.50.</p>
<div class="lb-trans"><p>周四交易时段，LQDA 的股价下跌 0.50 美元，达到 16.16 美元。该公司交易了 561,016 股，低于其平均交易量 1,039,819 股。该公司的市值为 13.8 亿美元，市盈率为-9.94，贝塔值为 0.24。Liquidia 的 12 个月低点为 8.26 美元，12 个月高点为 19.41 美元。该公司的 50 日移动平均价格为 14.72 美元，200 日移动平均价格为 13.50 美元。</p>
</div><p>Liquidia (NASDAQ:LQDA - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported ($0.45) earnings per share for the quarter, missing the consensus estimate of ($0.42) by ($0.03). The firm had revenue of $3.12 million for the quarter, compared to analysts' expectations of $3.23 million. Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%. On average, analysts expect that Liquidia will post -1.51 EPS for the current year.</p>
<div class="lb-trans"><p>Liquidia（纳斯达克：LQDA - 获取免费报告）于 5 月 8 日发布了季度财报。该公司报告每股收益为（0.45 美元），低于市场共识预期的（0.42 美元）3 美分。该公司季度收入为 312 万美元，而分析师预期为 323 万美元。Liquidia 的净利润率为-765.38%，股本回报率为-163.21%。分析师平均预计 Liquidia 在本年度的每股收益为-1.51 美元。</p>
</div><h2>Insider Transactions at Liquidia</h2>
<div class="lb-trans"><h2>Liquidia 的内部交易</h2>
</div><p>In related news, General Counsel Russell Schundler sold 5,964 shares of the stock in a transaction that occurred on Monday, April 14th. The stock was sold at an average price of $13.57, for a total transaction of $80,931.48. Following the completion of the transaction, the general counsel now directly owns 570,301 shares of the company's stock, valued at approximately $7,738,984.57. This represents a 1.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Jason Adair sold 1,856 shares of the firm's stock in a transaction that occurred on Monday, April 14th. The shares were sold at an average price of $13.57, for a total transaction of $25,185.92. Following the completion of the sale, the insider now owns 184,304 shares in the company, valued at $2,501,005.28. This represents a 1.00% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 33,138 shares of company stock valued at $450,233. 26.50% of the stock is currently owned by insiders.</p>
<div class="lb-trans"><p>在相关消息中，首席法律顾问 Russell Schundler 在 4 月 14 日的交易中出售了 5,964 股股票，平均售价为 13.57 美元，总交易额为 80,931.48 美元。交易完成后，首席法律顾问现在直接持有 570,301 股公司股票，价值约为 7,738,984.57 美元。这代表其持股比例减少了 1.03%。该出售在向 SEC 提交的文件中披露，文件可通过此超链接访问。此外，内部人士 Jason Adair 在 4 月 14 日的交易中出售了 1,856 股公司的股票，平均售价为 13.57 美元，总交易额为 25,185.92 美元。交易完成后，内部人士现在持有 184,304 股公司股票，价值为 2,501,005.28 美元。这代表其持股比例减少了 1.00%。该出售的披露信息可以在这里找到。在过去的九十天里，内部人士共出售了 33,138 股公司股票，价值为 450,233 美元。当前 26.50% 的股票由内部人士持有。</p>
</div><h2>Hedge Funds Weigh In On Liquidia</h2>
<div class="lb-trans"><h2>对 Liquidia 的对冲基金看法</h2>
</div><p>A number of large investors have recently modified their holdings of LQDA. Bluefin Capital Management LLC bought a new position in Liquidia in the 1st quarter worth about $250,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Liquidia by 15.2% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company's stock worth $1,796,000 after acquiring an additional 16,022 shares in the last quarter. Goldman Sachs Group Inc. increased its position in shares of Liquidia by 10.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company's stock valued at $12,703,000 after acquiring an additional 82,955 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Liquidia by 4.7% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company's stock worth $556,000 after buying an additional 1,700 shares in the last quarter. Finally, Boothbay Fund Management LLC boosted its holdings in Liquidia by 18.7% in the 1st quarter. Boothbay Fund Management LLC now owns 662,873 shares of the company's stock worth $9,777,000 after buying an additional 104,215 shares during the last quarter. 64.54% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>一些大型投资者最近修改了他们对 LQDA 的持股。Bluefin Capital Management LLC 在第一季度购买了 Liquidia 的新头寸，价值约为 250,000 美元。瑞银资产管理美国分部在第一季度将其在 Liquidia 的持股增加了 15.2%。瑞银资产管理美国分部现在持有 121,756 股公司股票，价值为 1,796,000 美元，此前在上个季度又增持了 16,022 股。高盛集团在第一季度将其在 Liquidia 的持股增加了 10.7%。高盛集团现在持有 861,231 股公司股票，价值为 12,703,000 美元，此前在此期间又增持了 82,955 股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Liquidia 的持股增加了 4.7%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.现在持有 37,681 股公司股票，价值为 556,000 美元，此前在上个季度又增持了 1,700 股。最后，Boothbay Fund Management LLC 在第一季度将其在 Liquidia 的持股增加了 18.7%。Boothbay Fund Management LLC 现在持有 662,873 股公司股票，价值为 9,777,000 美元，此前在上个季度又增持了 104,215 股。当前 64.54% 的股票由机构投资者持有。</p>
</div><h2>Liquidia Company Profile</h2>
<div class="lb-trans"><h2>Liquidia 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).</p>
<div class="lb-trans"><p>Liquidia Corporation 是一家生物制药公司，开发、生产和商业化各种满足美国患者需求的产品。其主要产品候选包括 YUTREPIA，一种用于治疗肺动脉高压（PAH）和与间质性肺病相关的肺高压（PH-ILD）的吸入干粉制剂。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Liquidia</li>
<li>What is Forex and How Does it Work?</li>
<li>These Are the Only 6 Stock Stocks in NVIDIA's 13F Portfolio</li>
<li>What is a Dividend Harvesting Strategy and How Can Investors Profit from it?</li>
<li>Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond?</li>
<li>What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story</li>
<li>3 Buy-and-Hold Stocks Long-Term Investors Can Love in Any Market</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Liquidia</li>
<li>外汇是什么，如何运作？</li>
<li>这些是 NVIDIA 13F 投资组合中仅有的 6 只股票</li>
<li>什么是股息收割策略，投资者如何从中获利？</li>
<li>Snowflake 突破！它能在 2025 年及以后继续上涨吗？</li>
<li>百分比涨幅告诉投资者什么，以及为什么它们不能告诉全部故事</li>
<li>3 只长期投资者在任何市场中都能喜爱的买入持有股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TFFEQQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=LQDA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Liquidia Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Liquidia 吗？</h2>
</div><p>Before you consider Liquidia, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Liquidia 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Liquidia wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Liquidia 并不在名单上。</p>
</div><p>While Liquidia currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Liquidia 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Liquidia（纳斯达克股票代码：LQDA）在 Wall Street Zen 获得评级上调